Westlake Village, CA, United States of America

Hq Han

This inventor holds 2 USPTO granted patents. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hq Han. Retrieved from https://idiyas.com/inventor/hq-han-zgwq31op

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 2.0


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hq Han: Inventor in Pulmonary Disease Research

Introduction

Hq Han is an inventor based in Westlake Village, California. His patent work includes inventions addressing biological pathways associated with pulmonary fibrosis and pulmonary arterial hypertension.

Latest Patents

Han’s listed patents include “Bifunctional Antagonists of Tumor Necrosis Factor Alpha and Transforming Growth Factor Beta and Method of Use Thereof to Treat Pulmonary Fibrosis and Pulmonary Arterial Hypertension” and “Bifunctional Antagonists of Activin and Tumor Necrosis Factor Alpha and Uses Thereof.” These titles describe approaches involving combined antagonists and their potential therapeutic uses. Han is associated with 2 patents.

Career Highlights

The available information identifies Han as an inventor on patents focused on therapeutic strategies for pulmonary conditions. The patent titles indicate research involving tumor necrosis factor alpha, transforming growth factor beta, and activin.

Collaborations

Han’s listed coworker is Xiaolan Zhou, reflecting a professional connection in the context of this patent work.

Conclusion

Hq Han’s patent portfolio centers on bifunctional antagonists and their potential applications in pulmonary disease, with his listed work connecting him to Xiaolan Zhou.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…